|
Phone: +1 314 576-6100 |
Address:
1945 CRAIG ROAD
ST. LOUIS, MISSOURI 63146 |
Company Description
Jones Pharma Incorporated manufactures, markets and distributes specialty pharmaceutical products. The company's product lines consist of thyroid treatment products related to the endocrine therapy. These include levothyroxine, liothyronine and methimazole. The other products are thrombin which is used as hemostatic agent and methohexital which is used as a general anesthetic agent in the critical care market. Major customers for the company's products include McKesson HBOC, INc., Bergen Brunswig Corp., Cardial Health, Inc. and other wholesalers. The company has incurred 1.5 million dollars towards the year 2000 expenses to date.
Key People
| Chairman, President & Chief Executive | D.M. JONES |
| Exec VP & Chief Operating Officer | G.A. FRANZ |
| Exec VP, Treasurer & Secretary | J.A. JONES |
Related Business Topics
Breaking News
BBC - November 10, 2009 12:51 AM
Quay Pharma said the move will allow it to take on larger scale projects A pharmaceuticals firm says it is to create 54 new jobs with a relocation of its research and development work from Merseyside to Flintshire. Quay Pharma aims to open offices and ...
BBC - November 09, 2009 10:56 PM
Quay Pharma said the move will allow it to take on larger scale projects A pharmaceuticals firm says it is to create 54 new jobs with a relocation of its research and development work from Merseyside to Flintshire. Quay Pharma aims to open offices and ...
Forbes.com - November 04, 2009 5:29 AM
, 08:06 AM EST Stocks on the move Real-time Equity news U.S. stock market report trademark ------------------------------------------------------------------------------ King Pharmaceuticals Inc has sued ZymoGenetics Inc , alleging trademark ...
Reuters UK - November 02, 2009 2:32 AM
* U.S. stock index futures pointed to a higher open on Wall Street on Monday, signalling a rebound after the previous session's steep losses, with futures for the S&P 500 SPc1 up 0.74 percent, Dow Jones DJc1 futures up 0.68 percent and Nasdaq 100 ...
Reuters - November 02, 2009 2:22 AM
* U.S. stock index futures pointed to a higher open on Wall Street on Monday, signalling a rebound after the previous session's steep losses, with futures for the S&P 500 SPc1 up 0.74 percent, Dow Jones DJc1 futures up 0.68 percent and Nasdaq 100 NDc1 ...
More Jones Pharma News
Pharmaceutical Companies
Daily Drug Pipeline Updates Pharmaceutical Company Profiles
www.biopharminsight.com
Daily Drug Pipeline Updates Pharmaceutical Company Profiles
www.biopharminsight.com
